Bio-View Ltd Asset Resilience Ratio
Bio-View Ltd asset resilience ratio. Bio-View Ltd (BIOV) has an Asset Resilience Ratio of 7.61% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Bio-View Ltd (BIOV) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Bio-View Ltd (2023–2024)
Asset resilience ratio of Bio-View Ltd from 2023 to 2024. This chart shows how Bio-View Ltd's Asset Resilience Ratio has changed over time. See Bio-View Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Bio-View Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Bio-View Ltd asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA2.15 Million | 7.61% |
| Total Liquid Assets | ILA2.15 Million | 7.61% |
Asset Resilience Insights
- Limited Liquidity: Bio-View Ltd maintains only 7.61% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bio-View Ltd Industry Peers by Asset Resilience Ratio
Compare Bio-View Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Bio-View Ltd Asset Resilience Ratio by Year (2023–2024)
Bio-View Ltd asset resilience ratio by year from 2023 to 2024. The table below shows the annual Asset Resilience Ratio data for Bio-View Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.10% | ILA2.72 Million ≈ $7.30K |
ILA33.62 Million ≈ $90.14K |
+4.70pp |
| 2023-12-31 | 3.39% | ILA1.42 Million ≈ $3.82K |
ILA41.95 Million ≈ $112.48K |
-- |
About Bio-View Ltd
Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company's products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatic… Read more